Showing results (21-30 of 183) with videos related to

Sort By:
Pageof 19
Drug and Alcohol Review|May 7, 2011
Definitions related to the use of pharmaceutical opioids: extramedical use, diversion, non-adherence and aberrant medication-related behavioursBriony Larance, Louisa Degenhardt, Nick Lintzeris, et al.
The International Journal on Drug Policy|July 22, 2008
Sexual health risk among dance drug users: cross-sectional comparisons with nationally representative dataLuke Mitcheson, Jim McCambridge, Angela Byrne, et al.
The International Journal on Drug Policy|November 30, 2010
The prevalence and correlates of buprenorphine inhalation amongst opioid substitution treatment (OST) clients in AustraliaDanielle Horyniak, Paul Dietze, Briony Larance, et al.
Drug and Alcohol Review|October 11, 2014
Senior nurses' perspectives on the transfer of opioid substitution treatment clients from clinics to community pharmacyJessica Bui, Carolyn Day, Jane Hanrahan, et al.
Dialogues in Clinical Neuroscience|October 22, 2015
Biological predictors of pharmacological therapy in anxiety disordersEduard Maron, David Nutt
Focus (American Psychiatric Publishing)|February 5, 2020
Biological Markers of Generalized Anxiety DisorderEduard Maron, David Nutt
CNS Spectrums|January 30, 2025
MDMA-assisted therapy: challenges, clinical trials, and the future of MDMA in treating behavioral disordersSteve O'Brien, David Nutt
The British Journal of Psychiatry : the Journal of Mental Science|September 4, 2007
Management of insomnia: treatments and mechanismsiSue Wilson, David Nutt
The British Journal of Psychiatry : the Journal of Mental Science|January 7, 2015
Making a medicine out of MDMABen Sessa, David Nutt
Dialogues in Clinical Neuroscience|September 5, 2017
Biological markers of generalized anxiety disorderEduard Maron, David Nutt
Pageof 19